| Description | Secoisolariciresinol diglucoside (LGM2605) was cytoprotective in an in vitro model of iron overload-induced redox-inflammatory damage. Secoisolariciresinol diglucoside (25 mg/kg b.w.) exerts the antihyperglycemic effect by preventing the liver from peroxidation damage through inhibition of ROS level mediated increased level of enzymatic and non-enzymatic antioxidants. |
| Synonyms | 亚麻木酚素, LGM2605 |
| molecular weight | 686.704 |
| Molecular formula | C32H46O16 |
| CAS | 158932-33-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | Ethanol: 91 mg/mL(132.5 mM) DMSO: 125 mg/mL(182.03 mM) Pyridine, Methanol: Soluble H2O: 50 mg/mL (72.8 mM) |
| References | 1. Tao YL, et al. Appl Microbiol Biotechnol. 2014 Mar;98(6):2519-31. 2. Puukila S, et al. PLoS One. 2015 Mar 30;10(3):e0122852. |
Secoisolariciresinol diglucoside
CAS No.: 158932-33-3
Secoisolariciresinol diglucoside (LGM2605) was cytoprotective in an in vitro model of iron overload-induced redox-inflam
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.